Cargando...
Taming expectations of metformin as a treatment to extend healthspan
The anti-hyperglycemic medication metformin has potential to be the first drug tested to slow aging in humans. While the Targeting Aging with Metformin (TAME) proposal and other small-scale clinical trials have the potential to support aging as a treatment indication, we propose that the goals of th...
Gardado en:
| Publicado en: | GeroScience |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer International Publishing
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544683/ https://ncbi.nlm.nih.gov/pubmed/30746605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11357-019-00057-3 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|